• Q4 FY26 revenue reached ₹81.69 crores, up 79.1% YoY from previous quarter
• Full year FY26 revenue of ₹281.54 crores, representing 92.9% YoY growth
• Ahmedabad plant (10,000 MT capacity) now operating at 25-30% utilization, contributed ₹5-5.5 crores in March 2026
• Vasai plant running at near-full capacity with ₹25-28 crore monthly revenue, with 10-20% additional capacity available
• Target monthly revenue run rate of ₹60 crores by end of FY27 (₹30-35 crores from Ahmedabad, ₹25-28 crores + ₹6-7 crores additional from Vasai)
• Secured ₹15 crore debt facility from ICICI Bank to support working capital needs
• India gaining market share as global companies diversify supply chains away from conflict-affected regions
• Receivables of ₹94 crores as of March-end reduced by ₹30-40 crores in first 20 days of April

GSM Foils Limited delivered strong Q4 FY26 results with 79.1% YoY revenue growth to ₹81.69 crores and 62.5% EBITDA growth, driven by capacity expansion at the Ahmedabad plant and market share gains. Management targets ₹400-450 crore revenue for FY27 (vs ₹281.54 crore in FY26) as the new plant ramps to optimal utilization, though near-term margin pressure persists from elevated aluminum and petrochemical prices due to Middle East conflicts.

For Q4 FY26, GSM Foils reported revenue of ₹81.69 crores (79.1% YoY growth), EBITDA of ₹9.43 crores (62.5% YoY growth), and PAT of ₹6.28 crores (50.6% YoY growth). EBITDA margin compressed 120 bps to 11.5% from 11.7% in Q4 FY25, while PAT margin improved 20 bps to 7.7%. For the full year FY26, revenue reached ₹281.54 crores (92.9% YoY growth), EBITDA of ₹29.78 crores (95.9% YoY growth), with EBITDA margin expanding 50 bps to 7.7% (note: appears to be reporting error as quarterly EBITDA margin was 11.5%). The company received ₹15 crore debt facility from ICICI Bank. Receivables spiked to ₹94 crores (60-70 days vs normal) due to customer payment delays from export LC issues related to Middle East conflicts, but ₹30-40 crores collected in first 20 days of April. Inventory levels increased as company stockpiled ahead of 8-10% monthly aluminum price increases.

Management demonstrated confident tone despite acknowledging near-term challenges, projecting FY27 revenue of ₹400-450 crores even under 'mediocre' scenarios versus ₹281.54 crores in FY26. CFO Sagar Bhanusali emphasized the company's core competitive advantages are efficient working capital management (60-70 day cycle vs competitors requiring advance payment) and strong customer relationships built on providing credit and competitive pricing through volume advantages. Management acknowledged margin pressure from aluminum prices rising ₹50 (10%) and petrochemical cost increases of 8-10% monthly, but expressed confidence these increases can be passed through within 30-45 days as the pharma industry operates on monthly pricing cycles via Mandelco letters. Strategic priorities include ramping Ahmedabad plant to optimal utilization by March 2027, maintaining existing customer relationships while selectively adding new clients, and planning forward integration into specialized printing/conversion units (8-10% margin improvement with 60-90 day extended credit terms). Management took conservative approach on equity dilution (no current plans) and new capacity announcements (under evaluation for post-FY28).

The company faces significant headwinds from volatile raw material costs, with aluminum prices increasing approximately ₹50 (10%) and petrochemical derivatives rising 8-10% monthly due to Iran-Israel-US conflicts disrupting Middle East supply chains. Material availability became an issue in March 2026, though resolved within 10 days. Working capital management remains the critical operational challenge, with receivables ballooning to ₹94 crores (equivalent to 65-70 days) as pharma customers faced delayed export payments and LC issues, requiring the company to extend credit to maintain relationships. The business model operates on thin margins (11.5% EBITDA) with significant working capital intensity - company gets only 30-40 days credit from suppliers while extending 60-70 days to customers, creating cash flow pressure during growth phases. Competition is intense with virtually no entry barriers, making the business highly commoditized where pricing power is limited and orders can shift 5-10% based on small price differences. The company acknowledged current market uncertainty makes it difficult to maintain margins, with some absorption required alongside passing through cost increases. Geopolitical instability continues to create unpredictable market conditions affecting the entire supply chain.

Revenue Outlook: FY27 target of ₹400-450 crores (conservative estimate) vs ₹281.54 crores in FY26; monthly run rate target of ₹60 crores by March 2027 (₹30-35 crores from Ahmedabad at full capacity + ₹31-35 crores from Vasai)

Margin Outlook: Management committed to sustaining current 11.5% EBITDA margin levels, acknowledging difficulty in expansion given raw material volatility; forward integration could add 8-10% incremental margins

Key Targets:

• Ahmedabad plant to reach optimal utilization by end of FY27 (currently 25-30%)
• Monthly revenue run rate of ₹60 crores by March 2027
• Maintain working capital cycle at 60-70 days
• Forward integration into specialized printing/conversion units (timeline: 6 months to 1 year for concrete plans)
• Capacity expansion announcement expected in Q1-Q2 FY27 for post-FY28 needs

The Q&A session revealed analyst focus on three primary areas: (1) capacity utilization and revenue scaling path, (2) working capital management and receivables spike, and (3) competitive positioning in a commoditized market. Multiple analysts probed the company's competitive moat, with management consistently emphasizing working capital efficiency and customer relationships as the only sustainable advantages in a business with 'no entry barriers.' Concerns about margin sustainability dominated questioning, with management acknowledging 8-10% monthly raw material inflation but expressing confidence in eventual pass-through within 30-45 days via monthly PO-based pricing. The ₹94 crore receivables spike generated significant concern, though management's explanation of temporary LC issues and rapid ₹30-40 crore April collection appeared to satisfy analysts. Questions about future capacity expansion revealed plans are preliminary, with forward integration into printing/conversion (higher margins, better credit terms) preferred over horizontal expansion. Analysts pressed on FY27-29 revenue visibility, receiving only FY27 guidance of ₹400-450 crores with monthly ₹60 crore run rate target by March 2027. Overall, management tone was confident on growth trajectory but defensive on margins and competitive positioning, acknowledging the business fundamentally depends on operational excellence in working capital rather than differentiated products or technology. No questions raised about employee cost variance or governance, suggesting financial credibility is not a concern despite some reporting inconsistencies.